Targeting Mouse Double Minute 2 Homolog (MDM2) Oncogene in Breast Adenocarcinoma

Athanasios Niotis1, Sofianiki Mastronikoli2, Despoina Spyropoulou3

  • 1Department of Breast Surgery, "Henry Dunant" Medical Hospital, Athens, Greece.

Maedica
|July 8, 2026
PubMed
Summary

MDM2 oncogene amplification drives breast adenocarcinoma (BAC) progression by disrupting the Tp53-MDM2 balance. Targeted therapies against MDM2 show promise for specific BAC genetic profiles.